Healthcare Roundup – Jazz to acquire GW Pharma in cash-and-stock deal valued at $7.2B; Anavex gains after favorable data from Cassava Sciences in Alzheimer’s Feb 4, 2021 Life Science
Healthcare Roundup – Pfizer runs early on schedule to supply 200M COVID vaccine doses to U.S. by May; Cassava surges after favorable trial data for simufilam in Alzheimer’s disease Feb 3, 2021 Life Science
Healthcare Roundup – Illumina surges after patent win; announces collaboration in China; BioCryst climbs after being named ‘the most undervalued stock in the market Feb 1, 2021 Life Science
Healthcare Roundup – AstraZeneca gets European nod for COVID-19 vaccine; eHealth announces $225M strategic investment from H.I.G. capital Jan 30, 2021 Life Science
Healthcare Roundup – AstraZeneca COVID-19 shot is only for those aged 18-64 in Germany, Hims & Hers Health soars after Cathie Wood’s ETF discloses stake Jan 28, 2021 Life Science
Healthcare Roundup – Lilly bamlanivimab combo therapy lowers COVID-19 hospitalizations, JNJ earnings release brightens U.S. biopharma outlook Jan 26, 2021 Life Science
Healthcare Roundup – Intuitive Surgical earns mixed reviews from analysts despite earnings beat; Amyris acquires Terasana Brand for offering clean cannabinoid consumer products Jan 22, 2021 Life Science
Healthcare Roundup – Moderna says dosing underway in Takeda-led early-stage COVID vaccine trial in Japan; Gene editors raise equity as shares climb amid investor interest Jan 21, 2021 Life Science
Healthcare Roundup – Adamis Pharma soars on Tempol IND submission for COVID-19 treatment; MindMed kicks off early stage trial for LSD-MDMA cocktail Jan 20, 2021 Life Science
Healthcare Roundup – Moderna drops as company acknowledges allergic reactions to COVID-19 shot, Eli Lilly upgraded to buy at Mizuho on positive donanemab data Jan 19, 2021 Life Science
Healthcare Roundup – COVID-19 Jabs: Israel trades data for doses; U.K. to vaccinate all adults by September;Grifols to trial new immunoglobulin therapy against COVID-19 Jan 18, 2021 Life Science
Healthcare Roundup – Norway says deaths after COVID-19 jab may be from side effects, Sorrento could nearly quadruple in value: analyst Jan 15, 2021 Life Science
Healthcare Roundup – The world will have to live with COVID forever; Gilead attributes long term growth to oncology franchise, excludes remdesivir Jan 14, 2021 Life Science
Healthcare Roundup – Gilead and VIR Biotechnology tie up in chronic hepatitis B virus cure setting, AstraZeneca’s COVID-19 vaccine is set for Indian rollout Jan 12, 2021 Life Science
Healthcare Roundup – JNJ’s single-dose COVID-19 vaccine viewed favorably by analysts; Eli Lilly up 20% after donanemab shows clinical benefit in mid-stage Alzheimer’s study Jan 12, 2021 Life Science
Healthcare Roundup – Moderna’s COVID-19 vaccine authorized in Israel; Moderna and NIH to study the effects of halving the COVID-19 shot Jan 5, 2021 Life Science
Healthcare Roundup – EU regulator remains undecided on Moderna’s COVID-19 jab; U.K. rolls out AstraZeneca-Oxford’s COVID-19 vaccine Jan 4, 2021 Life Science
Healthcare Roundup – Inovio gains 9% after positive peer-reviewed data for COVID-19 jab, New Wave completes acquisition of aromatherapy retailer Dec 24, 2020 Life Science